International Cannabis Weekly: 390

SWITZERLAND’S 7000 RECREATIONAL CANNABIS PILOT PARTICIPANTS SHOW TENDANCY TO ‘LOW-RISK CONSUMPTION’

The preliminary findings from Switzerland’s seven active pilot trials, involving around three per cent of the country’s active cannabis consumers, have been published by a local university.

READ MORE  »

INSIDE UK’S LARGEST MEDICAL CANNABIS FACILITY: HOW CURALEAF LABORATORIES IS TRANSFORMING PATIENT ACCESS

READ MORE »

NEW YORK OPENS DOORS TO OUT-OF-STATE BRANDS AS BILL TO LEGALISE INTOXICATING HEMP ADVANCES

READ MORE »

• Five more companies pass novel foods CBD safety assessment since start of 2024. 
• Legalising cannabis in the UK could generate billions in tax revenue, study finds.
• German election results already impacting cannabis market and regulatory landscape.
• Dublin airport medication seizure highlights systemic failures in Ireland’s medical cannabis policy. 
• CannCare charity pushes for patient rights, advocating prescription over prosecution for cannabis use.
• Germany’s medical cannabis imports surge in 2024 as demand continues to grow.

SAVE £100 PER TICKET »

• Federal interstate cannabis ban fuels illicit market and harms legal businesses, report says.
• National Hemp Association calls for industrial hemp reform to boost US market growth.
• Maine coalition pushes for mandatory potency and contaminant testing in cannabis products.
• ILGM and Leafly launch home grow tour to empower cannabis cultivators across the US.
• House Democrats say cannabis reform could drive major economic gains nationwide.
• Alabama bill seeks to change medical cannabis licensing process for greater transparency.

FIND OUT MORE »

• Emerging trends in Canadian cannabis sales highlight shifting consumer demands.
• MediPharm set to offload its cannabis facility in British Columbia to Rubicon Organics.
• Adastra Holdings announces new strategic initiatives for cannabis product expansion.
• Canopy Growth launches $200M at-the-market program to strengthen financial position.
• Simply Solventless completes acquisition, expanding its presence in cannabis concentrate market.
• Village Farms International expands medical cannabis distribution network to New Zealand.

• Colombian president urges Congress to legalise cannabis, pushing for regulatory reform.
• Brazilian UFLa lab earns certification for genetically modified medicinal cannabis research.
• Bahamas to begin issuing medical cannabis licences starting from 1 July 2025.
• Uruguay grants licences to four new companies for adult-use cannabis production.

• New Zealand medical marijuana company enters receivership after failed Australian expansion.
• SAS-B cannabis approvals up 47% in the last two months, according to latest TGA data.
• Malaysia opens doors for cannabis-based products in medical treatments under regulation.
• Victoria clears medical cannabis users to drive legally under new framework, expanding patient rights.

• Popular Cape Town nursery now legally sells a variety of cannabis plants to the public, expanding accessibility.
• Israeli government approves new reforms to expand medical cannabis access and patient eligibility.